Association between Helicobacter pylori infection, mismatch repair, HER2 and tumor-infiltrating lymphocytes in gastric cancer
Descripción del Articulo
BACKGROUND The influence of Helicobacter-pylori (H. pylori) infection and the characteristics of gastric cancer (GC) on tumor-infiltrating lymphocyte (TIL) levels has not been extensively studied. Analysis of infiltrating-immune-cell subtypes as well as survival is necessary to obtain comprehensive...
| Autores: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | artículo |
| Fecha de Publicación: | 2024 |
| Institución: | Instituto Nacional de Enfermedades Neoplásicas |
| Repositorio: | INEN-Institucional |
| Lenguaje: | inglés |
| OAI Identifier: | oai:repositorio.inen.sld.pe:20.500.14703/402 |
| Enlace del recurso: | https: //doi.org/10.4251/wjgo.v16.i6.2487 https://hdl.handle.net/20.500.14703/402 |
| Nivel de acceso: | acceso abierto |
| Materia: | Gastric cancer Helicobacter pylori HER2 Lymphocytes Macrophages Mismatch repair https://purl.org/pe-repo/ocde/ford#3.02.21 |
| id |
INEN_e55dd69f0157332fe699342b6a7953a4 |
|---|---|
| oai_identifier_str |
oai:repositorio.inen.sld.pe:20.500.14703/402 |
| network_acronym_str |
INEN |
| network_name_str |
INEN-Institucional |
| repository_id_str |
. |
| dc.title.none.fl_str_mv |
Association between Helicobacter pylori infection, mismatch repair, HER2 and tumor-infiltrating lymphocytes in gastric cancer |
| title |
Association between Helicobacter pylori infection, mismatch repair, HER2 and tumor-infiltrating lymphocytes in gastric cancer |
| spellingShingle |
Association between Helicobacter pylori infection, mismatch repair, HER2 and tumor-infiltrating lymphocytes in gastric cancer Castaneda, CA Gastric cancer Helicobacter pylori HER2 Lymphocytes Macrophages Mismatch repair https://purl.org/pe-repo/ocde/ford#3.02.21 |
| title_short |
Association between Helicobacter pylori infection, mismatch repair, HER2 and tumor-infiltrating lymphocytes in gastric cancer |
| title_full |
Association between Helicobacter pylori infection, mismatch repair, HER2 and tumor-infiltrating lymphocytes in gastric cancer |
| title_fullStr |
Association between Helicobacter pylori infection, mismatch repair, HER2 and tumor-infiltrating lymphocytes in gastric cancer |
| title_full_unstemmed |
Association between Helicobacter pylori infection, mismatch repair, HER2 and tumor-infiltrating lymphocytes in gastric cancer |
| title_sort |
Association between Helicobacter pylori infection, mismatch repair, HER2 and tumor-infiltrating lymphocytes in gastric cancer |
| author |
Castaneda, CA |
| author_facet |
Castaneda, CA Castillo, M Bernabe, LA Sanchez, J Fassan, M Tello, K Wistuba, II Passiuri, IC Ruiz, E Barreda, F Valdivia, D Bazan, Y Abad-Licham, M Mengoa, C Fuentes, H Montenegro, P Poquioma, E Alatrista, R Flores, CJ Taxa, L |
| author_role |
author |
| author2 |
Castillo, M Bernabe, LA Sanchez, J Fassan, M Tello, K Wistuba, II Passiuri, IC Ruiz, E Barreda, F Valdivia, D Bazan, Y Abad-Licham, M Mengoa, C Fuentes, H Montenegro, P Poquioma, E Alatrista, R Flores, CJ Taxa, L |
| author2_role |
author author author author author author author author author author author author author author author author author author author |
| dc.contributor.author.fl_str_mv |
Castaneda, CA Castillo, M Bernabe, LA Sanchez, J Fassan, M Tello, K Wistuba, II Passiuri, IC Ruiz, E Sanchez, J Barreda, F Valdivia, D Bazan, Y Abad-Licham, M Mengoa, C Fuentes, H Montenegro, P Poquioma, E Alatrista, R Flores, CJ Taxa, L |
| dc.subject.none.fl_str_mv |
Gastric cancer Helicobacter pylori HER2 Lymphocytes Macrophages Mismatch repair |
| topic |
Gastric cancer Helicobacter pylori HER2 Lymphocytes Macrophages Mismatch repair https://purl.org/pe-repo/ocde/ford#3.02.21 |
| dc.subject.ocde.none.fl_str_mv |
https://purl.org/pe-repo/ocde/ford#3.02.21 |
| description |
BACKGROUND The influence of Helicobacter-pylori (H. pylori) infection and the characteristics of gastric cancer (GC) on tumor-infiltrating lymphocyte (TIL) levels has not been extensively studied. Analysis of infiltrating-immune-cell subtypes as well as survival is necessary to obtain comprehensive information. AIM To determine the rates of deficient mismatch-repair (dMMR), HER2-status and H. pylori infection and their association with TIL levels in GC. METHODS Samples from 503 resected GC tumors were included and TIL levels were evaluated following the international-TILs-working-group recommendations with assessment of the intratumoral (IT), stromal (ST) and invasive-border (IB) compartments. The density of CD3, CD8 and CD163 immune cells, and dMMR and HER2-status were determined by immunohistochemistry (IHC). H. pylori infection was evaluated by routine histology and quantitative PCR (qPCR) in a subset of samples. RESULTS dMMR was found in 34.4%, HER2+ in 5% and H. pylori-positive in 55.7% of samples. High IT-TIL was associated with grade-3 (P = 0.038), while ST-TIL with grade-1 (P < 0.001), intestinal-histology (P < 0.001) and no-recurrence (P = 0.003). dMMR was associated with high TIL levels in the ST (P = 0.019) and IB (P = 0.01) compartments, and STCD3 (P = 0.049) and ST-CD8 (P = 0.05) densities. HER2-was associated with high IT-CD8 (P = 0.009). H. pylorinegative was associated with high IT-TIL levels (P = 0.009) when assessed by routine-histology, and with high TIL levels in the 3 compartments (P = 0.002-0.047) and CD8 density in the IT and ST compartments (P = 0.001) when assessed by qPCR. A longer overall survival was associated with low IT-CD163 (P = 0.003) and CD8/CD3 (P = 0.001 in IT and P = 0.002 in ST) and high IT-CD3 (P = 0.021), ST-CD3 (P = 0.003) and CD3/CD163 (P = 0.002). CONCLUSION TIL levels were related to dMMR and H. pylori-negativity. Low CD8/CD3 and high CD163/CD3 were associated with lower recurrence and longer survival. |
| publishDate |
2024 |
| dc.date.accessioned.none.fl_str_mv |
2025-02-05T17:29:49Z |
| dc.date.available.none.fl_str_mv |
2025-02-05T17:29:49Z |
| dc.date.issued.fl_str_mv |
2024 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article |
| dc.type.version.none.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.doi.none.fl_str_mv |
https: //doi.org/10.4251/wjgo.v16.i6.2487 |
| dc.identifier.uri.none.fl_str_mv |
https://hdl.handle.net/20.500.14703/402 |
| dc.identifier.journal.none.fl_str_mv |
World Journal of Gastrointestinal Oncology |
| url |
https: //doi.org/10.4251/wjgo.v16.i6.2487 https://hdl.handle.net/20.500.14703/402 |
| identifier_str_mv |
World Journal of Gastrointestinal Oncology |
| dc.language.iso.none.fl_str_mv |
eng |
| language |
eng |
| dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess |
| dc.rights.uri.none.fl_str_mv |
https://creativecommons.org/licenses/by/4.0/ |
| eu_rights_str_mv |
openAccess |
| rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0/ |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.publisher.none.fl_str_mv |
Baishideng Publishing Group Inc |
| dc.publisher.country.none.fl_str_mv |
US |
| publisher.none.fl_str_mv |
Baishideng Publishing Group Inc |
| dc.source.none.fl_str_mv |
reponame:INEN-Institucional instname:Instituto Nacional de Enfermedades Neoplásicas instacron:INEN |
| instname_str |
Instituto Nacional de Enfermedades Neoplásicas |
| instacron_str |
INEN |
| institution |
INEN |
| reponame_str |
INEN-Institucional |
| collection |
INEN-Institucional |
| bitstream.url.fl_str_mv |
https://repositorio.inen.sld.pe/backend/api/core/bitstreams/0aa32d9a-7647-4cf8-b927-4abd967f9cfa/download https://repositorio.inen.sld.pe/backend/api/core/bitstreams/0715509d-36ca-4308-9a96-09fdf8ba9df6/download https://repositorio.inen.sld.pe/backend/api/core/bitstreams/de8d3f88-7d06-4438-9f95-c96ed060c254/download |
| bitstream.checksum.fl_str_mv |
3b7bb7a92399241a52c45cb467c4df79 38a27a951dfed1a0f008fd21d42196aa f9f76a021052eedb8669268efd3d9fe0 |
| bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
| repository.name.fl_str_mv |
Repositorio del Instituto Nacional de Enfermedades Neoplásicas |
| repository.mail.fl_str_mv |
repositorio@inen.sld.pe |
| _version_ |
1868438565265866752 |
| spelling |
PublicationCastaneda, CACastillo, MBernabe, LASanchez, JFassan, MTello, KWistuba, IIPassiuri, ICRuiz, ESanchez, JBarreda, FValdivia, DBazan, YAbad-Licham, MMengoa, CFuentes, HMontenegro, PPoquioma, EAlatrista, RFlores, CJTaxa, L2025-02-05T17:29:49Z2025-02-05T17:29:49Z2024https: //doi.org/10.4251/wjgo.v16.i6.2487https://hdl.handle.net/20.500.14703/402World Journal of Gastrointestinal OncologyBACKGROUND The influence of Helicobacter-pylori (H. pylori) infection and the characteristics of gastric cancer (GC) on tumor-infiltrating lymphocyte (TIL) levels has not been extensively studied. Analysis of infiltrating-immune-cell subtypes as well as survival is necessary to obtain comprehensive information. AIM To determine the rates of deficient mismatch-repair (dMMR), HER2-status and H. pylori infection and their association with TIL levels in GC. METHODS Samples from 503 resected GC tumors were included and TIL levels were evaluated following the international-TILs-working-group recommendations with assessment of the intratumoral (IT), stromal (ST) and invasive-border (IB) compartments. The density of CD3, CD8 and CD163 immune cells, and dMMR and HER2-status were determined by immunohistochemistry (IHC). H. pylori infection was evaluated by routine histology and quantitative PCR (qPCR) in a subset of samples. RESULTS dMMR was found in 34.4%, HER2+ in 5% and H. pylori-positive in 55.7% of samples. High IT-TIL was associated with grade-3 (P = 0.038), while ST-TIL with grade-1 (P < 0.001), intestinal-histology (P < 0.001) and no-recurrence (P = 0.003). dMMR was associated with high TIL levels in the ST (P = 0.019) and IB (P = 0.01) compartments, and STCD3 (P = 0.049) and ST-CD8 (P = 0.05) densities. HER2-was associated with high IT-CD8 (P = 0.009). H. pylorinegative was associated with high IT-TIL levels (P = 0.009) when assessed by routine-histology, and with high TIL levels in the 3 compartments (P = 0.002-0.047) and CD8 density in the IT and ST compartments (P = 0.001) when assessed by qPCR. A longer overall survival was associated with low IT-CD163 (P = 0.003) and CD8/CD3 (P = 0.001 in IT and P = 0.002 in ST) and high IT-CD3 (P = 0.021), ST-CD3 (P = 0.003) and CD3/CD163 (P = 0.002). CONCLUSION TIL levels were related to dMMR and H. pylori-negativity. Low CD8/CD3 and high CD163/CD3 were associated with lower recurrence and longer survival.application/pdfengBaishideng Publishing Group IncUSinfo:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by/4.0/Gastric cancerHelicobacter pyloriHER2LymphocytesMacrophagesMismatch repairhttps://purl.org/pe-repo/ocde/ford#3.02.21Association between Helicobacter pylori infection, mismatch repair, HER2 and tumor-infiltrating lymphocytes in gastric cancerinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionreponame:INEN-Institucionalinstname:Instituto Nacional de Enfermedades Neoplásicasinstacron:INENORIGINALCastañeda-Alfamirano, Carlos Alberto; 2024application/pdf29585186https://repositorio.inen.sld.pe/backend/api/core/bitstreams/0aa32d9a-7647-4cf8-b927-4abd967f9cfa/download3b7bb7a92399241a52c45cb467c4df79MD51trueAnonymousREADTEXTCastañeda-Alfamirano, Carlos Alberto; 2024.txtWritten by FormatFilter org.dspace.app.mediafilter.TikaTextExtractionFilter on 2025-03-29T20:42:22Z (GMT).Extracted texttext/plain64253https://repositorio.inen.sld.pe/backend/api/core/bitstreams/0715509d-36ca-4308-9a96-09fdf8ba9df6/download38a27a951dfed1a0f008fd21d42196aaMD54falseAnonymousREADTHUMBNAILCastañeda-Alfamirano, Carlos Alberto; 2024.jpgWritten by FormatFilter org.dspace.app.mediafilter.PDFBoxThumbnail on 2025-03-29T20:42:22Z (GMT).Generated Thumbnailimage/jpeg41676https://repositorio.inen.sld.pe/backend/api/core/bitstreams/de8d3f88-7d06-4438-9f95-c96ed060c254/downloadf9f76a021052eedb8669268efd3d9fe0MD55falseAnonymousREAD20.500.14703/402oai:repositorio.inen.sld.pe:20.500.14703/4022026-02-15T17:13:20.183Zhttps://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessopen.accesshttps://repositorio.inen.sld.peRepositorio del Instituto Nacional de Enfermedades Neoplásicasrepositorio@inen.sld.pe |
| score |
12.821158 |
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).